In turn, this finding is consistent with the report that exogenous FGF treatment dependent on FGFR-induced activation of PI3K-Akt-Rac1 signaling inhibits RhoA activity and protects the blood-brain barrier after intracerebral hemorrhage in mice (31). Here, AKT1 is linked to intracerebral hemorrhage.